Campbell & CO Investment Adviser LLC Cytokinetics Inc Transaction History

Campbell & CO Investment Adviser LLC

  • $1.3 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$47.86 - $75.05 $598,537 - $938,575
12,506 New
12,506 $677,000
Q3 2023

Nov 08, 2023
BUY
$29.46 - $36.61 $417,742 - $519,129
14,180 Added 101.44%
28,159 $829,000
Q2 2023

Aug 11, 2023
BUY
$32.62 - $40.75 $455,994 - $569,644
13,979 New
13,979 $455,000
Q2 2022

Aug 09, 2022
BUY
$33.93 - $48.92 $689,729 - $994,445
20,328 New
20,328 $799,000
Q2 2019

Jul 10, 2019
SELL
$7.95 - $11.25 $348,559 - $493,245
-43,844 Closed
0 $0
Q1 2019

May 10, 2019
BUY
$5.95 - $10.19 $260,871 - $446,770
43,844 New
43,844 $355,000

Others Institutions Holding CYTK

# of Institutions
410
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.76B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email